Modalis Therapeutics

About:

Modalis is a biotech company that develops therapeutics using CRISPR based technology.

Website: http://www.modalistx.com/jp

Twitter/X: modalistx

Top Investors: Mitsubishi UFJ Capital, SMBC Venture Capital, SBI Investment, Mizuho Capital, UTokyo Innovation Platform

Description:

Modalis Therapeutics Corporation is an biotech company focusing on developing transformative therapeutics for unmet medical needs using its proprietary technologies on CRISPR and protein engineering platforms. The company has a strong foundation on intellectual property licensed from the University of Tokyo.

Total Funding Amount:

$38.5M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Tokyo, Tokyo, Japan

Founded Date:

2016-01-01

Contact Email:

otoiawase(AT)modalistx.com

Founders:

Haru Morita, Osamu Nureki

Number of Employees:

11-50

Last Funding Date:

2019-04-10

IPO Status:

Public

Industries:

© 2025 bioDAO.ai